CS logo
small CS logo
Saitama Children's Medical Center

Saitama, Japan
Children's hospital in Saitama
1番地2 Shintoshin, Chuo Ward, Saitama, 330-8777

About Saitama Children's Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
BioMarin Pharmaceutical
5
Janssen Research & Development, LLC
2
Japan Rhabdomyosarcoma Study Group
2
Shire
2
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2
Alios Biopharma Inc.
1
Bayer
1
Children's Hospital of Philadelphia
1
OPKO Health, Inc.
1
Pfizer
1
Reata Pharmaceuticals, Inc.
1
Total Rows: 11

Clinical Trials at Saitama Children's Medical Center


During the past decade, Saitama Children's Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years225522220022000000111122Started TrialsCompleted Trails2016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
2004-05-01
Unknown status
41
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
2004-05-01
Unknown status
32
A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia
2012-04-01
2021-02-01
Completed
363
A Study of ALS-008176 in Infants Hospitalized With RSV
2014-07-23
2018-02-15
Completed
183
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
2014-11-01
2016-08-01
Completed
26
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
2010-03-01
2030-01-01
Recruiting
150,000
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
2016-07-05
2023-01-27
Completed
373
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
2017-03-02
2020-10-30
Completed
187

Rows per page:

1–19 of 19

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Saitama Children's Medical Center" #1 sponsor was "BioMarin Pharmaceutical" with 5 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored, "Shire" with 2 trials sponsored and "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Children's Medical Center" #1 collaborator was "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBioMarin Pharmaceutical: 5BioMarin Pharmaceutical: 5Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2JapanRhabdomyosarcomaStudy Group: 2JapanRhabdomyosarcomaStudy Group: 2Shire: 2Shire: 2Zogenix InternationalLimited, Inc., asubsidiary of Zogenix,Inc.: 2Zogenix InternationalLimited, Inc., asubsidiary of Zogenix,Inc.: 2Alios Biopharma Inc.: 1Alios Biopharma Inc.: 1Bayer: 1Bayer: 1Children's Hospital ofPhiladelphia: 1Children's Hospital ofPhiladelphia: 1OPKO Health, Inc.: 1OPKO Health, Inc.: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsAgency for HealthcareResearch and Quality(AHRQ): 1Agency for HealthcareResearch and Quality(AHRQ): 1Regeneron Pharmaceuticals: 1Regeneron Pharmaceuticals: 1Takeda DevelopmentCenter Americas, Inc.:1Takeda DevelopmentCenter Americas, Inc.:1

Clinical Trials Conditions at Saitama Children's Medical Center


According to Clinical.Site data, the most researched conditions in "Saitama Children's Medical Center" are "Achondroplasia" (5 trials), "Nervous System Diseases" (2 trials), "Sarcoma" (2 trials), "Alport Syndrome" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Saitama Children's Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Saitama Children's Medical Center


Most popular intervention types in "Saitama Children's Medical Center" are "Drug" (17 trials), "Biological" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "BMN 111" (3 trials), "Matching Placebo" (2 trials), "SHP615" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Saitama Children's Medical Center


The vast majority of trials in "Saitama Children's Medical Center" are 19 trials for "All" genders.

Clinical Trials Status at Saitama Children's Medical Center


Currently, there are NaN active trials in "Saitama Children's Medical Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Saitama Children's Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saitama Children's Medical Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 2: 5Phase 2: 5Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 11Completed: 11Active, not recruiting: 3Active, not recruiting: 3Recruiting: 3Recruiting: 3Unknown status: 2Unknown status: 2